PKR is a novel functional direct player that coordinates skeletal muscle differentiation via p38MAPK/AKT pathways

被引:23
作者
Alisi, A. [1 ,2 ]
Spaziani, A. [1 ,3 ]
Anticoli, S. [1 ,3 ]
Ghidinelli, M. [1 ,2 ]
Balsano, C. [1 ,2 ,3 ]
机构
[1] Univ Roma La Sapienza, Lab Mol Virol & Oncol, Fdn A Cesalpino, Rome, Italy
[2] TOSINVEST Sanita SPA, IRCCS San Raffaele Pisana, Lab Dev Pathol, Rome, Italy
[3] Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy
关键词
p38MATK; PKR; PI3K/Akt; muscle; differentiation;
D O I
10.1016/j.cellsig.2007.11.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Myogenic differentiation is a highly orchestrated multistep process controlled by extracellular growth factors that modulate largely unknown signals into the cell affecting the muscle-transcription program. P38MAPK-dependent signalling, as well as PI3K/Akt pathway, has a key role in the control of muscle gene expression at different stages during the myogenic process. P38MAPK affects the activities of transcription factors, such as MyoD and myogenin, and contributes, together with PI3K/Akt pathway, to control the early and late steps of myogenic differentiation. The aim of our work was to better define the role of PKR, a dsRNA-activated protein kinase, as potential component in the differentiation program of C2C12 murine myogenic cells and to correlate its activity with p38MAPK and PI3K/Akt myogenic regulatory pathways. Here, we demonstrate that PKR is an essential component of the muscle development machinery and forms a functional complex with p38MAPK and/or Akt, contributing to muscle differentiation of committed myogenic cells in vitro. Inhibition of endogenous PKR activity by a specific (si)RNA and a PKR dominant-negative interferes with the myogenic program of C2C12 cells, causing a delay in activation of myogenic specific genes and inducing the formation of thinner myofibers. In addition, the construction of three PKR mutants allowed us to demonstrate that both N and C-terminal regions of PKR are critical for the interaction with p38MAPK and Akt. The novel discovered complex permits PKR to timely regulate the inhibition/activation of p38MAPK and Akt, controlling in this way the different steps characterizing skeletal muscle differentiation. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:534 / 542
页数:9
相关论文
共 34 条
[1]   Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells [J].
Alisi, A ;
Mele, R ;
Spaziani, A ;
Tavolaro, S ;
Palescandolo, E ;
Balsano, C .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (01) :25-31
[2]   Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo [J].
Bodine, SC ;
Stitt, TN ;
Gonzalez, M ;
Kline, WO ;
Stover, GL ;
Bauerlein, R ;
Zlotchenko, E ;
Scrimgeour, A ;
Lawrence, JC ;
Glass, DJ ;
Yancopoulos, GD .
NATURE CELL BIOLOGY, 2001, 3 (11) :1014-1019
[3]   Genetic and epigenetic control of skeletal muscle development [J].
Brand-Saberi, B .
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2005, 187 (03) :199-207
[4]   Skeletal muscle formation in vertebrates [J].
Buckingham, M .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (04) :440-448
[5]   The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis [J].
Cabane, C ;
Coldefy, AS ;
Yeow, K ;
Dérijard, B .
CELLULAR SIGNALLING, 2004, 16 (12) :1405-1415
[6]   pRb: Master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specification transcription [J].
De Falco, G. ;
Comes, F. ;
Simone, C. .
ONCOGENE, 2006, 25 (38) :5244-5249
[7]  
De Falco M, 2006, EUR J HISTOCHEM, V50, P19
[8]   Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase [J].
Eley, H. L. ;
Russell, S. T. ;
Tisdale, M. J. .
BRITISH JOURNAL OF CANCER, 2007, 96 (08) :1216-1222
[9]   The dsRNA protein kinase PKR:: Virus and cell control [J].
Garcia, M. A. ;
Meurs, E. F. ;
Esteban, M. .
BIOCHIMIE, 2007, 89 (6-7) :799-811
[10]   Impact of protein kinase PKR in cell biology:: from antiviral to antiproliferative action [J].
Garcia, M. A. ;
Gil, J. ;
Ventoso, I. ;
Guerra, S. ;
Domingo, E. ;
Rivas, C. ;
Esteban, M. .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2006, 70 (04) :1032-+